Investigation of Biofilm Formation Among Methicillin-Resistant Staphylococcus aureus Isolated from Children

AUTHORS

Roghayeh Samadi 1 , Zohreh Ghalavand 1 , Bahram Nikmanesh 2 , 3 , Narges Nodeh Farahani 4 , Maryam Yasini 5 , Mozhgan Esmaeili Benvidi 1 , Gita Eslami 1 , *

1 Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran

3 Zoonosis Research Center, Tehran University of Medical Sciences, Tehran, Iran

4 Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

5 Department of Microbiology and Immunology, Kashan University of Medical Sciences, Kashan, Iran

How to Cite: Samadi R, Ghalavand Z, Nikmanesh B, Nodeh Farahani N, Yasini M, et al. Investigation of Biofilm Formation Among Methicillin-Resistant Staphylococcus aureus Isolated from Children, Arch Pediatr Infect Dis. 2018 ; 6(3):e61635. doi: 10.5812/pedinfect.61635.

ARTICLE INFORMATION

Archives of Pediatric Infectious Diseases: 6 (3); e61635
Published Online: September 27, 2017
Article Type: Research Article
Received: October 29, 2017
Revised: January 11, 2017
Accepted: March 9, 2017
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: The aim of the present study was to investigate biofilm formation among Methicillin-resistant Staphylococcus aureus (MRSA) isolated from children referring to a pediatric hospital in Tehran.

Methods: In total, 98 MRSA isolates were collected from children referring to a pediatric hospital during 2014 - 2015. All the isolates were confirmed to be MRSA using PCR amplification of the mecA gene. The antibiotic susceptibility patterns of the isolates were determined using the Kirby-Bauer disk-diffusion and E-test methods. In order to assess the ability of biofilm formation among the isolates, Congo red agar (CRA) and Microtiter Plate (Mtp) methods were used.

Results: All the isolates were found to be susceptible to linezolid and vancomycin and, likewise, the majority was susceptible to minocycline and rifampicin. CRA and Mtp methods showed that 81.6% and 63.3% of the MRSA isolates, respectively, were biofilm producers.

Conclusions: The early identification of S. aureus and detection of biofilm formation by the Mtp method are essential steps towards the prevention of the most serious nosocomial infections.

Keywords

MRSA Biofilm Formation Antibiotic Resistance Children E-Test

Copyright © 2017, Archives of Pediatric Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited

1. Background

Staphylococcus aureus represents one of the most serious Gram-positive bacterial infections in nosocomial and community settings (1). The pathogenicity of S. aureus is caused by the expression of virulence factors, which can lead to superficial skin lesions or more-serious infections such as endocarditis, bacteremia, pneumonia, and osteomyelitis (2, 3). The development of high levels of penicillin resistance followed by the spread of strains resistant to the semi synthetic derivative of penicillin (e.g. methicillin) and other antibiotics has made the therapy of Staphylococcal infections an international challenge (4). Finding Methicillin resistant Staphylococcus aureus (MRSA) strains just two years after the clinical use of penicillinase-resistant Penicillin put specialists into difficulty with treating these infections (5). Vancomycin is considered the treatment of choice for MRSA cases, but recently there are reports on the emergence of vancomycin resistance in S. aureus isolates (6). The biofilm formation on host surfaces is considered an important virulence factor in S. aureus isolates (7, 8). Biofilm-forming Staphylococcus aureus strains are extremely difficult to eradicate because biofilm impairs antibiotic penetration and prevents normal immune responses (9, 10).

There are many methods to identify biofilm formation such as tube test, Congo Red Agar (CRA), Microtiter Plate test (Mtp), bioluminescent assay, and light or fluorescence microscopic examination (11, 12). These methods are often subject to severe analytical limitation and unable to detect bacterial adherence accurately (13, 14). However, the Mtp and CRA methods have been used to investigate biofilm formation more frequent than other methods (15-17).

In the present study, attempts were made to determine the prevalence of antimicrobial resistance and biofilm formation among MRSA isolated from children referring to a pediatric hospital in Tehran using Mtp and CRA methods.

2. Methods

2.1. Staphylococcus aureus Isolates

In total, 98 MRSA isolates were collected from 98 children referring to a pediatric hospital in Tehran during 2014 - 2015. All strains were examined by techniques appropriate for diagnosis of Staphylococcus spp. such as microscopic morphology examination, catalase test, coagulase test, mannitol fermentation on Mannitol Salt Agar and deoxyribonuclease (DNase) test (Merck, Germany) (18). All the isolates were confirmed to be S. aureus and MRSA by using PCR amplification of nuc and mecA genes, respectively (19, 20).

2.2. Antibiotic Susceptibility Test

Antimicrobial Susceptibility Test (AST) was performed according to the guidelines of clinical and laboratory standards institute (CLSI) (2013) (21). The used antibiotic disks in AST included penicillin (10 IU), cefoxitin (30 μg), clindamycin (2 μg), Linezolid (30 μg), minocycline (30 μg), trimethoprim-sulfamethoxazole (25 μg), gentamicin (10 μg), erythromycin (15 μg), and rifampicin (5 μg), all purchased from Rosco, Denmark. Vancomycin susceptibility test was performed by E-test (Liofilchem, Italy) and the results were interpreted according to the CLSI guidelines (2013). S. aureus ATCC 25923 was used as quality control.

2.3. Bacterial DNA Extraction

Genomic DNA was extracted from pure cultures using High Pure PCR Template Preparation Kit (Roche, Germany), according to the manufacturer’s guidelines.

2.4. Detection of nuc and mecA Genes

In the present study, all MRSA isolates were screened for the nuc and mecA genes using PCR and primers described in Table 1. A 25 μL PCR reaction mixture consisted of 12.5 μL of Master Mix (SinaClon, Iran), 2 μL of the DNA template, 1 μL of each primer (20 pmol), and 8.5 μL of ddH2O. DNA amplification was performed in a Thermocycler (Eppendorf, Hamburg, Germany) with an initial denaturation step at 95°C for 5 minutes, 30 amplification cycles each with 45 seconds at 95°C, 45 seconds at 54°C and 55°C for nuc and mecA genes, respectively, and 45 seconds at 72°C, followed by an additional extension step of 5 minutes at 72°C. The amplified products were electrophoresed on 1.5% agarose gel.

Table 1. Target Genes and Their Primers Used in the Study
PrimerSequence (5’ - 3’)Products Sizes, bpAnnealing, °CRef.
NucF-GCGATTGATGGTGATACGGTT27054(19)
R-AGCCAAGCCTTGACGAACTAAAGC
mecAF-GTAGAAATGACTGAACGTCCGATAA31055(20)
R-CCAATTCCACATTGTTTCGCTCTAA

The gel was stained with Ethidium bromide (0.5 g/mL), visualized using UV transilluminator. The PCR products of nuc and mecA genes were sequenced and documented in Gen Bank, NCBI.

2.5. Detection of Biofilm Formation

2.5.1. Microtiter Plate Assay (Mtp)

The 98 clinical isolates of MRSA were screened for their ability to form biofilm using Mtp method according to Christensen et al. (1985) with some modifications (22). Briefly, bacterial isolates were grown in brain heart infusion (BHI) with 1% glucose (Merck, Germany) and incubated at 37°C overnight (13). Cultures were diluted 1:20 in fresh BHI-0.1% glucose. Then, 200 μL of the diluted solution was added to wells of a flat-bottomed polystyrene microtitre plate and incubated for 48 hours at 37°C. The negative control wells contained 200 μL of BHI-0.1% glucose. The wells were gently washed 3 times with phosphate-buffered saline (PBS; pH 7.2), fixed with sodium acetate (2%) for 10 minutes, dried at room temperature, and then strained with 0.1% crystal violet. After removing the crystal violet solution, the wells were washed with PBS to remove unbound dye. The optical densities (ODs) of the plates were observed at 630 nm using a Microtiter plate reader. Each assay was performed in duplicate. As a negative control, brain heart infusion broth with 1% glucose medium was used to determine the background OD. OD cut-off was then determined as an average OD of negative control + 3 × standard deviation of negative control. The OD cut-off value was separately calculated for each Microtiter plate. Biofilm formation by isolates was calculated and categorized according to the absorbance of the crystal violet-stained attached cells (23, 24) (Table 2).

Table 2. Classification of Biofilm Formation Abilities by Microtiter Plate Method
Cut-Off Value CalculationMean of OD ValuesBiofilm Formation Abilities
OD > 4 × ODcOD > 0.2Strong
2 × ODc < OD ≤ 4 × ODc0.1 < OD ≤ 0.2Moderate
ODc < OD ≤ 2 × ODc0.05 < OD ≤ 0.1Weak
OD ≤ ODcOD ≤ 0.05Negative

2.5.2. Congo Red Agar Method (CRA)

Phenotypic production of biofilm in all MRSA isolates was assessed using culture on CRA plates as previously explained (12). Briefly, CRA plates were prepared by adding 0.8 g of Congo red (Sigma, USA) to 1 liter of brain heart infusion agar (Merck, Germany). Next, the CRA was autoclaved in 120°C for 15 minutes and then, 36 g of Saccharose (Merck, USA) was added using filtering. The plates were incubated for 48 hours at 37°C. The morphology of colonies was then interpreted based on colony color as pink, brown, and black (25, 26).

2.6. Statistical Analysis

The relationship between biofilm formation and drug resistance among MRSA isolates was evaluated by the Pearson Chi-Square test using SPSS version 21. P values less than 0.05 were considered significant.

3. Results

3.1. Samples Collection

In total, 98 clinical specimens were collected from blood (10.2%), throat (52%), wound (5.1%), sputum (5.1%), and other sources (27.6%). Participants were 52% girls and 48% boys. The mean age was 54 months. The youngest and the oldest patients had 1 month and 17 years of age, respectively.

3.2. Antibiogram Profile of Isolates

All the 98 (100%) MRSA isolates were found to be resistant to cefoxitin (30 μg) using disc diffusion method. Figure 1 shows the results of antibiotic resistance testing of the MRSA isolates for the nine antibiotics studied. The pattern of Minimal Inhibitory Concentration of vancomycin on the MRSA isolates was determined with concentrations varying from 0.19 to 2.5 μg/mL.

Antimicrobial Resistance Pattern of MRSA Isolates
Figure 1. Antimicrobial Resistance Pattern of MRSA Isolates

3.3. Detection of nuc and mecA using PCR

PCR revealed the presence of nuc and mecA genes (270 and 310 bp, respectively) in all 98 isolates (100%). The PCR products of nuc and mecA genes were sequenced and they were documented with Accession numbers KU163299 and KX024711, respectively, in Gen Bank, NCBI.

3.4. Detection of Biofilm Formation

3.4.1. Microtiter Plate Assay

The Mtp assay results showed that MRSA isolates were attached at different amounts. Attachment abilities were strong in 1 (1%) strain, moderate in 8 (8.2%) strains, and weak in 53 (54.1%) strains, while 36 (36.7%) of them had no attachment ability (Table 3).

Table 3. Biofilm Formation of MRSA Isolates in Mtp and CRA Methods
MethodBiofilm formationNumberPercentage
Congo red agar methodBlack5657.1
Brown2424.5
Pink1717.3
Microtiter plate assayStrong11
Moderate88.2
Weak5354.1
Negative3636.7

3.4.2. Congo Red Method

In this method, 57.1%, 24.5%, and 17.3% of MRSA isolates, respectively, showed black colonies (Strong biofilm producers), brown colonies (Weak biofilm producers), and red colonies (non-biofilm producers).

4. Discussion

The attachment and biofilm formation on surfaces causes bacterial resistance to inappropriate conditions such as antibiotics and immune response (27, 28). All of the 98 MRSA isolates were examined for their potential for biofilm formation. Using the Mtp method, 62 (63.3%) isolates were found to be biofilm producers among which, 9 (9.2%) strains were highly biofilm-positive (OD630 > 0.1) and 53 (54.1%) were low-grade biofilm producer, while 36 (36.7%) strains produced no biofilm. Other studies have reported a slightly higher number of biofilm producers among Staphylococcal species (23, 29).

In the CRA method, biofilm formation was observed in 80 (81.6%) isolates whereas 17 (17.3%) strains did not show any biofilm formation. This finding is in agreement with that of the study by Turkyilmaz et al. who detected biofilm production in 74.4% of isolates using CRA method (30). Among the phenotypic methods, Mtp assay has been reported as the gold standard for biofilm formation (14). CRA method is easy to perform and interpret, but due to its low specificity and sensitivity, we do not recommend it for detection of biofilm formation (31). When S. aureus assumes the biofilm phenotype, the associated infections are often extremely difficult to treat (32).

In the present study, antimicrobial resistance was 100% for penicillin and cefoxitin, 57% for erythromycin, 54% for clindamycin, 24% for trimethoprim- sulfamethoxazole, 22% for gentamycin, 12% for rifampicin, and 6% for minocycline, but all these isolates were susceptible to vancomycin and linezolid. Therefore, vancomycin, linezolid, and other glycopeptide drugs have remained the last resorts for treatment of S. aureus, especially MRSA-induced infections (33). A similar study was performed by Yousefi and his colleagues in 2016 in Iran. They determined the biofilm formation and antibiotic resistance pattern of Staphylococcus aureus isolated from urinary tract infection. They reported that 69.2% of S. aureus isolates were biofilm producers and resistance to four antibiotics, namely nitrofurantoin (71.4%/28.6%), tetracycline (57.7%/42.3%), erythromycin, and ciprofloxacin (56%/44) was higher among biofilm producers than among non-biofilm producers (29). These findings were consistent with our findings in the present study.

CharanKaur and Khare conducted a similar study in 2013 in India on biofilm investigation and antimicrobial susceptibility of MRSA isolates. Out of 231 isolates, 182 (78.8%) of the Methicillin resistant Staphylococcus aureus isolates were found to form biofilm (34).

In our study, the antibiotic resistance pattern was higher in biofilm-producing MRSA than in non-biofilm-producers (Figure 2) although statistical analysis showed no significant relationship between biofilm formation and some antibiotic resistance; a finding that was previously reported by other researchers, too (9, 35).

Antimicrobial Resistance in Biofilm Producers and Non-Producers
Figure 2. Antimicrobial Resistance in Biofilm Producers and Non-Producers

The increased resistance of biofilm producing strains to antibiotics may be because the biofilm bacteria exhibit a slow rate of metabolism and divide infrequently, resulting in the decreased sensitivity to antibiotics targeted at cell wall synthesis (36). However, even antibiotics that target cellular functions, such as protein and DNA synthesis, cannot be effective on biofilm-producing organisms as they are at a quiescent state (37).

4.1. Conclusion

Unfortunately, the prevalence of Methicillin resistant Staphylococcus aureus isolates is rising and biofilm formation has an important role in the development of antibiotic resistance. Thus, early identification of these isolates and detection of biofilm formation by Mtp method are the essential steps towards the prevention of most serious nosocomial infections.

Acknowledgements

References

  • 1.

    Mohammed MK, Rasheed MN, Nadeer MI. Detection of biofilm-associated genes in clinical staphylococcus aureus isolates from iraqi patient. Int J Sci Nature.

  • 2.

    Machuca MA, Gonzalez CI, Sosa LM. Methicillin-resistant Staphylococcus aureus causes both community-associated and health care-associated infections in children at the Hospital Universitario de Santander. Biomedica. 2014;34 Suppl 1:163-9. doi: 10.1590/S0120-41572014000500019. [PubMed: 24968048].

  • 3.

    Tangchaisuriya U, Yotpanya W, Kitti T, Sitthisak S. Distribution among Thai children of methicillin-resistant Staphylococcus aureus lacking cna, fnbA and icaAD. Southeast Asian J Trop Med Public Health. 2014;45(1):149-56. [PubMed: 24964664].

  • 4.

    Havaei SA, Azimian A, Fazeli H, Naderi M, Ghazvini K, Samiee SM, et al. Genetic Characterization of Methicillin Resistant and Sensitive, Vancomycin Intermediate Staphylococcus aureus Strains Isolated from Different Iranian Hospitals. ISRN Microbiol. 2012;2012:215275. doi: 10.5402/2012/215275. [PubMed: 23762750].

  • 5.

    Mirzaee M, Najar Peerayeh S, Ghasemian AM. Detection of icaABCD genes and biofilm formation in clinical isolates of methicillin resistant Staphylococcus aureus. Iran J Pathol. 2014;9(4):257-62.

  • 6.

    Jasmine R, Daisy P, Selvakumar BN. Evaluating the antibacterial activity of elephantopus scaber extracts on clinical isolates of ß-lactamase producing methicillin resistant staphylococcus aureus from UTI patients. Int J Pharmacol. 2007;3(2):165-9. doi: 10.3923/ijp.2007.165.169.

  • 7.

    Cramton SE, Gerke C, Schnell NF, Nichols WW, Gotz F. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun. 1999;67(10):5427-33. [PubMed: 10496925].

  • 8.

    Eftekhar F, Dadaei T. Biofilm formation and detection of icaAB genes in clinical isolates of methicillin resistant Staphylococcus aureus. Iran J Basic Med Sci. 2011;14(2):132-6. doi: 10.22038/ijbms.2011.4978.

  • 9.

    Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15(2):167-93. doi: 10.1128/CMR.15.2.167-193.2002. [PubMed: 11932229].

  • 10.

    Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001;358(9276):135-8. [PubMed: 11463434].

  • 11.

    Christensen GD, Simpson WA, Bisno AL, Beachey EH. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun. 1982;37(1):318-26. [PubMed: 6179880].

  • 12.

    Freeman DJ, Falkiner FR, Keane CT. New method for detecting slime production by coagulase negative staphylococci. J Clin Pathol. 1989;42(8):872-4. doi: 10.1136/jcp.42.8.872. [PubMed: 2475530].

  • 13.

    Mathur T, Singhal S, Khan S, Upadhyay DJ, Fatma T, Rattan A. Detection of biofilm formation among the clinical isolates of Staphylococci: an evaluation of three different screening methods. Indian J Med Microbiol. 2006;24(1):25-9. doi: 10.4103/0255-0857.19890. [PubMed: 16505551].

  • 14.

    Zufferey J, Rime B, Francioli P, Bille J. Simple method for rapid diagnosis of catheter-associated infection by direct acridine orange staining of catheter tips. J Clin Microbiol. 1988;26(2):175-7. [PubMed: 2449453].

  • 15.

    Hassan A, Usman J, Kaleem F, Omair M, Khalid A, Iqbal M. Evaluation of different detection methods of biofilm formation in the clinical isolates. Braz J Infect Dis. 2011;15(4):305-11. doi: 10.1590/S1413-86702011000400002. [PubMed: 21860999].

  • 16.

    Ruzicka F, Hola V, Votava M, Tejkalova R, Horvat R, Heroldova M, et al. Biofilm detection and the clinical significance of Staphylococcus epidermidis isolates. Folia Microbiol (Praha). 2004;49(5):596-600. doi: 10.1007/BF02931540. [PubMed: 15702552].

  • 17.

    Iqbal M, Khalid A, Omair M, Kaleem F, Usman J, Hassan A. Detection and antibiotic susceptibility pattern of biofilm producing Gram positive and Gram negative bacteria isolated from a tertiary care hospital of Pakistan. Malays J Microbiol. 2011;7:57-60. doi: 10.21161/mjm.25410.

  • 18.

    Sasirekha B, Usha M, Amruta A, Ankit S, Brinda N, Divya R. Evaluation and comparison of different phenotypic tests to detect methicillin resistant Staphylococcus aureus and their biofilm production. Int J PharmTech Res. 2012;4(2):532-41.

  • 19.

    Chakraborty SP, KarMahapatra S, Bal M, Roy S. Isolation and identification of vancomycin resistant Staphylococcus aureus from post operative pus sample. Al Ameen J Med Sci. 2011;4(2):152-68.

  • 20.

    McClure JA, Conly JM, Lau V, Elsayed S, Louie T, Hutchins W, et al. Novel multiplex PCR assay for detection of the staphylococcal virulence marker Panton-Valentine leukocidin genes and simultaneous discrimination of methicillin-susceptible from -resistant staphylococci. J Clin Microbiol. 2006;44(3):1141-4. doi: 10.1128/JCM.44.3.1141-1144.2006. [PubMed: 16517915].

  • 21.

    Wikler MA. Performance standards for antimicrobial susceptibility testing: Seventeenth informational supplement. Clinical and Laboratory Standards Institute. 2013.

  • 22.

    Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM, et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol. 1985;22(6):996-1006. [PubMed: 3905855].

  • 23.

    Ghellai L, Hassaine H, Klouche N, Khadir A, Aissaoui N, Nas F, et al. Detection of biofilm formation of a collection of fifty strains of Staphylococcus aureus isolated in Algeria at the University Hospital of Tlemcen. Afr J Bacteriol Res. 2014;6(1):1-6. doi: 10.5897/jbr2013.0122.

  • 24.

    Stepanovic S, Vukovic D, Jezek P, Pavlovic M, Svabic-Vlahovic M. Influence of dynamic conditions on biofilm formation by staphylococci. Eur J Clin Microbiol Infect Dis. 2001;20(7):502-4. doi: 10.1007/s100960100534. [PubMed: 11561809].

  • 25.

    Handke LD, Conlon KM, Slater SR, Elbaruni S, Fitzpatrick F, Humphreys H, et al. Genetic and phenotypic analysis of biofilm phenotypic variation in multiple Staphylococcus epidermidis isolates. J Med Microbiol. 2004;53(Pt 5):367-74. doi: 10.1099/jmm.0.05372-0. [PubMed: 15096544].

  • 26.

    Arciola CR, Campoccia D, Gamberini S, Cervellati M, Donati E, Montanaro L. Detection of slime production by means of an optimised Congo red agar plate test based on a colourimetric scale in Staphylococcus epidermidis clinical isolates genotyped for ica locus. Biomaterials. 2002;23(21):4233-9. doi: 10.1016/S0142-9612(02)00171-0. [PubMed: 12194526].

  • 27.

    Yazdani R, Oshaghi M, Havayi A, Pishva E, Salehi R, Sadeghizadeh M, et al. Detection of icaAD gene and biofilm formation in Staphylococcus aureus isolates from wound infections. Iran J Public Heaith. 2006;35(2):25-8.

  • 28.

    Taj Y, Essa F, Aziz F, Kazmi SU. Study on biofilm-forming properties of clinical isolates of Staphylococcus aureus. J Infect Dev Ctries. 2012;6(5):403-9. [PubMed: 22610706].

  • 29.

    Yousefi M, Pourmand MR, Fallah F, Hashemi A, Mashhadi R, Nazari-Alam A. Characterization of Staphylococcus aureus Biofilm Formation in Urinary Tract Infection. Iran J Public Health. 2016;45(4):485-93. [PubMed: 27252918].

  • 30.

    Türkyilmaz S, Kaya O. Determination of some virulence factors in Staphylococcus spp. isolated from various clinical samples. Turk J Vet Anim Sci. 2006;30(1):127-32.

  • 31.

    Khan F, Shukla I, Rizvi M, Mansoor T, Sharma SC. Detection of biofilm formation in staphylococcus aureus. Does it have a role in treatment of MRSA infections? Trends Med Res. 2011;6(2):116-23. doi: 10.3923/tmr.2011.116.123.

  • 32.

    Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2(2):95-108. doi: 10.1038/nrmicro821. [PubMed: 15040259].

  • 33.

    Ghasemian A, Najar Peerayeh S, Bakhshi B, Mirzaee M. Comparison of Biofilm Formation between Methicillin-Resistant and Methicillin-Susceptible Isolates of Staphylococcus aureus. Iran Biomed J. 2016;20(3):175-81. [PubMed: 26948126].

  • 34.

    CharanKaur D, Khare A. Biofilm formation and antibiotic susceptibility pattern in MRSA strains in a tertiary care rural hospital. Indian J Basic App Med Res. 2013;3(1):37-44.

  • 35.

    Stickler DJ. Bacterial biofilms and the encrustation of urethral catheters. Biofouling. 1996;9(4):293-305. doi: 10.1080/08927019609378311.

  • 36.

    Monroe D. Looking for chinks in the armor of bacterial biofilms. PLoS Biol. 2007;5(11). e307. doi: 10.1371/journal.pbio.0050307. [PubMed: 18001153].

  • 37.

    Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Microbiol. 2007;5(1):48-56. doi: 10.1038/nrmicro1557. [PubMed: 17143318].

  • COMMENTS

    LEAVE A COMMENT HERE: